ARTICLE | Company News
Advanced Biomedical Systems, Biohit deal
November 25, 2013 8:00 AM UTC
Biohit acquired exclusive, worldwide development and commercialization rights to the UFT300 test for Helicobacter pylori infection from Advanced Biomedical for €350,000 ($472,605). UFT300 detects H. p...